NCT01427387View on ClinicalTrials.gov

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
HealthyPharmacokinetics of ASP0456
Interventions
DRUG

ASP0456

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY